Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor

被引:0
|
作者
Martínez C. [1 ]
García-Martín E. [2 ]
Alonso-Navarro H. [3 ]
Jiménez-Jiménez F.J. [3 ]
Benito-León J. [4 ]
García-Ferrer I. [3 ]
Vázquez-Torres P. [3 ]
Puertas I. [3 ]
Zurdo J.M. [4 ]
López-Alburquerque T. [5 ]
Agúndez J.A.G. [1 ]
机构
[1] Department of Pharmacology and Psychiatry, Medical School, University of Extremadura, Badajoz
[2] Department of Biochemistry and Molecular Biology, School of Biological Sciences, University of Extremadura
[3] Department of Medicine-Neurology, Príncipe de Asturias Hospital, University of Alcalá, Alcalá de Henares (Madrid)
[4] Móstoles Hospital, Móstoles (Madrid)
[5] University Hospital of Salamanca, Salamanca
关键词
CYP2C19; CYP2C8; CYP2C9; Essential tremor; Genetics; Polymorphism;
D O I
10.1007/BF02685892
中图分类号
学科分类号
摘要
To identify low-penetrance genes related to sporadic essential tremor (ET) at the CYP2Clocus, located in chromosome 10 q23.33. Leukocytary DNA from 200 ET patients and a control group of 300 unrelated healthy individuals with known CYP2C19 genotypes was studied for common CYP2C8 and CYP2C9 allelic variants by using amplification-restriction analyses. Patients with ET showed the following differences compared with healthy subjects: a 1.6-fold reduction in the frequency for CYP2C8*3 (p ≤ 0.006), a 1.35-fold reduction of CYP2C9*2 (p ≤ 0.05) and a 1.52-fold reduction in the frequency for CYP2C9*3 (p ≤ 0.07). The frequency for patients with ET carrying at least one defective allele was 1.33-fold reduced as compared with healthy subjects (p ≤ 0.002). In addition, a disruption of the CYP2C8*3/ CYP2C9*2 linkage disequilibrium was observed in ET patients, with a 2.1-fold reduction in the percentage for carriers of the haplotype CYP2C8*3 plus CYP2C9*2 in ET patients (p ≤ 0.0001). These findings were independent of gender, age, age of onset, or clinical symptoms. These results suggest that alterations at the CYP2C gene locus are associated with the risk for ET. Copyright © 2007 Humana Press Inc. All rights of any nature whatsoever reserved.
引用
收藏
页码:195 / 204
页数:9
相关论文
共 50 条
  • [31] Influence of CYP2C8☆13 and CYP2C8☆14 Alleles on Amiodarone N-Deethylation
    Hanioka, Nobumitsu
    Matsumoto, Kimiaki
    Saito, Yoshiro
    Narimatsu, Shizuo
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 108 (05) : 359 - 362
  • [32] Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants
    Hiratsuka, Masahiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (11) : 1748 - 1759
  • [33] Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate
    VandenBrink, Brooke M.
    Foti, Robert S.
    Rock, Dan A.
    Wienkers, Larry C.
    Wahlstrom, Jan L.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (09) : 1546 - 1554
  • [34] Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population
    Polonikov, Alexey
    Kharchenko, Alexander
    Bykanova, Marina
    Sirotina, Svetlana
    Ponomarenko, Irina
    Bocharova, Anna
    Vagaytseva, Kseniya
    Stepanov, Vadim
    Bushueva, Olga
    Churnosov, Mikhail
    Solodilova, Maria
    GENE, 2017, 627 : 451 - 459
  • [35] The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
    Sigrid Haeggström
    Magnus Ingelman-Sundberg
    Svante Pääbo
    Hugo Zeberg
    The Pharmacogenomics Journal, 2022, 22 : 247 - 249
  • [36] The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
    Haeggstrom, Sigrid
    Ingelman-Sundberg, Magnus
    Paabo, Svante
    Zeberg, Hugo
    PHARMACOGENOMICS JOURNAL, 2022, 22 (04): : 247 - 249
  • [37] Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study
    Jorge Vicente
    Fabricio González-Andrade
    Antonia Soriano
    Ana Fanlo
    Begoña Martínez-Jarreta
    Blanca Sinués
    Molecular Biology Reports, 2014, 41 : 1267 - 1272
  • [38] CYP2C18: the orphan in the CYP2C family
    Zubiaur, Pablo
    Gaedigk, Andrea
    PHARMACOGENOMICS, 2022, 23 (16) : 913 - 916
  • [39] Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study
    Vicente, Jorge
    Gonzalez-Andrade, Fabricio
    Soriano, Antonia
    Fanlo, Ana
    Martinez-Jarreta, Begona
    Sinues, Blanca
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1267 - 1272
  • [40] COMPARISON OF THE EFFECT OF CHRONIC KIDNEY DISEASE (CKD) ON PHARMACOKINETICS OF CYP1A2, CYP2C8, CYP2C9 AND CYP2C19 SUBSTRATES
    Tan, M-L
    Yoshida, K.
    Zhao, P.
    Zhang, L.
    Galetin, A.
    Huang, S-M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S10 - S11